Cargando…

Prevention of chemotherapy‐induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle

BACKGROUND: Toxicity of chemotherapy on skeletal muscles and the heart may significantly contribute to cancer cachexia, mortality, and decreased quality of life. Doxorubicin (DOX) is an effective cytostatic agent, which unfortunately has toxic effects on many healthy tissues. Blocking of activin rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hulmi, Juha J., Nissinen, Tuuli A., Räsänen, Markus, Degerman, Joni, Lautaoja, Juulia H., Hemanthakumar, Karthik Amudhala, Backman, Janne T., Ritvos, Olli, Silvennoinen, Mika, Kivelä, Riikka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879968/ https://www.ncbi.nlm.nih.gov/pubmed/29230965 http://dx.doi.org/10.1002/jcsm.12265

Ejemplares similares

Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses
por: Nissinen, Tuuli A., et al.
Publicado: (2018)

Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes
por: Nissinen, T. A., et al.
Publicado: (2016)

Differentiation of Murine C2C12 Myoblasts Strongly Reduces the Effects of Myostatin on Intracellular Signaling
por: Lautaoja, Juulia H., et al.
Publicado: (2020)

Angiogenesis and angiocrines regulating heart growth
por: Hemanthakumar, Karthik Amudhala, et al.
Publicado: (2020)

Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver
por: Hentilä, Jaakko, et al.
Publicado: (2019)

Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury
por: Magga, Johanna, et al.
Publicado: (2019)

Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota—A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?
por: Pekkala, Satu, et al.
Publicado: (2019)

Cardiovascular disease risk factors induce mesenchymal features and senescence in mouse cardiac endothelial cells
por: Hemanthakumar, Karthik Amudhala, et al.
Publicado: (2021)

Muscle NAD(+) depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins
por: Hulmi, J.J., et al.
Publicado: (2020)

Branched-Chain Amino Acid Deprivation Decreases Lipid Oxidation and Lipogenesis in C2C12 Myotubes
por: Karvinen, Sira, et al.
Publicado: (2022)

Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle
por: Rinnankoski-Tuikka, Rita, et al.
Publicado: (2012)

Effects of Long-Term Physical Activity and BCAA Availability on the Subcellular Associations between Intramyocellular Lipids, Perilipins and PGC-1α
por: Fachada, Vasco, et al.
Publicado: (2023)

Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments
por: Hulmi, Juha J., et al.
Publicado: (2021)

NAD(+) repletion with niacin counteracts cancer cachexia
por: Beltrà, Marc, et al.
Publicado: (2023)

Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling
por: Kivelä, Riikka, et al.
Publicado: (2019)

ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia
por: Huot, Joshua R., et al.
Publicado: (2020)

Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice
por: Kivelä, Riikka, et al.
Publicado: (2008)

Exercise training improves adipose tissue metabolism and vasculature regardless of baseline glucose tolerance and sex
por: Honkala, Sanna Maria, et al.
Publicado: (2020)

Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
por: Puolakkainen, Tero, et al.
Publicado: (2017)

Characterization of RNA helicase A as component of STAT6-dependent enhanceosome
por: Välineva, Tuuli, et al.
Publicado: (2006)

Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models
por: Myllärniemi, Marjukka, et al.
Publicado: (2014)

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
por: Olsen, Oddrun Elise, et al.
Publicado: (2015)

ACVR1 Function in Health and Disease
por: Valer, José Antonio, et al.
Publicado: (2019)

Characterization of Fibrodysplasia Ossificans Progessiva relevant Acvr1/Acvr2 Activin receptors in medaka (Oryzias latipes)
por: Trumpp, Michael, et al.
Publicado: (2023)

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)

PGC-1 isoforms and their target genes are expressed differently in human skeletal muscle following resistance and endurance exercise
por: Silvennoinen, Mika, et al.
Publicado: (2015)

Long-Term Health-Related Quality of Life (HRQoL) After Redo-Fundoplication
por: Kivelä, Antti J., et al.
Publicado: (2021)

The effect of ACVR1B/TGFBR1/ACVR1C signaling inhibition on oocyte and granulosa cell development during in vitro growth culture
por: AKIMOTO, Yuki, et al.
Publicado: (2023)

ACVR1 mutation and Fibrodysplasia Ossificans Progressiva in Chinese children
por: Ho, Assunta CH, et al.
Publicado: (2011)

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
por: Taylor, Kathryn R, et al.
Publicado: (2014)

Genomic Context and Mechanisms of the ACVR1 Mutation in Fibrodysplasia Ossificans Progressiva
por: Ravazzolo, Roberto, et al.
Publicado: (2021)

Comparative analysis of silencing expression of myostatin (MSTN) and its two receptors (ACVR2A and ACVR2B) genes affecting growth traits in knock down chicken
por: Bhattacharya, T. K., et al.
Publicado: (2019)

ACVR1 Gene Mutation in Sporadic Korean Patients with Fibrodysplasia Ossificans Progressiva
por: Lee, Dong Yeon, et al.
Publicado: (2009)

MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1
por: Wang, Yongxia, et al.
Publicado: (2018)

ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma
por: Asnaghi, Laura, et al.
Publicado: (2018)

Does the expression of the ACVR2A gene affect the development of colorectal cancer?
por: Wodziński, Damian, et al.
Publicado: (2019)

Non-additive effects of ACVR2A in preeclampsia in a Philippine population
por: Amosco, Melissa D., et al.
Publicado: (2019)

Activation of AcvR1-Mediated Signaling Results in Semilunar Valve Defects
por: Syed, Shabber, et al.
Publicado: (2022)

Inhibition of RNA Binding in SND1 Increases the Levels of miR-1-3p and Sensitizes Cancer Cells to Navitoclax
por: Lehmusvaara, Saara, et al.
Publicado: (2022)

VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
por: Kivelä, Riikka, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2ae5cj62ht1s1hle3bhhr18aad